SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-21-000152
Filing Date
2021-07-21
Accepted
2021-07-21 08:00:45
Documents
17
Period of Report
2021-07-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20210720.htm   iXBRL 8-K 54045
2 EX-99.1 exhibit991_bodupdatexvfi.htm EX-99.1 14478
6 GRAPHIC exhibit991_bodupdatexvfi001.jpg GRAPHIC 284006
7 GRAPHIC exhibit991_bodupdatexvfi002.jpg GRAPHIC 296681
8 GRAPHIC exhibit991_bodupdatexvfi003.jpg GRAPHIC 303385
9 GRAPHIC exhibit991_bodupdatexvfi004.jpg GRAPHIC 172550
  Complete submission text file 0001485003-21-000152.txt   1675360

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20210720.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20210720_lab.xml EX-101.LAB 24993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20210720_pre.xml EX-101.PRE 13190
10 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20210720_htm.xml XML 11729
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 211102791
SIC: 2834 Pharmaceutical Preparations